A follow-up study analyzed IDH1 codon 132 mutations in a large series of 685 brain tumors comprising all major glioma subtypes and reported IDH1 mutation frequencies of up to 70% in diffuse astrocytomas, while virtually no mutations were detected in pilocytic astrocytomas [9]. This evidence concerns the gene IDH1 and central nervous system cancer.